Table of Content

1 Report Overview
1.1 Brand Drugs Definition
1.2 Market by Type
1.2.1 Global Brand Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Biopharmaceutical
1.2.3 Chemistry Medicine
1.3 Market Segment by Application
1.3.1 Global Brand Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Brand Drugs Sales
2.1 Global Brand Drugs Revenue Estimates and Forecasts 2018-2034
2.2 Global Brand Drugs Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Brand Drugs Revenue by Region
2.3.1 Global Brand Drugs Revenue by Region (2018-2024)
2.3.2 Global Brand Drugs Revenue by Region (2024-2034)
2.4 Global Brand Drugs Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Brand Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Brand Drugs Sales Quantity by Region
2.6.1 Global Brand Drugs Sales Quantity by Region (2018-2024)
2.6.2 Global Brand Drugs Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Brand Drugs Sales Quantity by Manufacturers
3.1.1 Global Brand Drugs Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Brand Drugs Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Brand Drugs Sales in 2022
3.2 Global Brand Drugs Revenue by Manufacturers
3.2.1 Global Brand Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Brand Drugs Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Brand Drugs Revenue in 2022
3.3 Global Brand Drugs Sales Price by Manufacturers
3.4 Global Key Players of Brand Drugs, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Brand Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Brand Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Brand Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Brand Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Brand Drugs Sales Quantity by Type
4.1.1 Global Brand Drugs Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Brand Drugs Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Brand Drugs Sales Quantity Market Share by Type (2018-2034)
4.2 Global Brand Drugs Revenue by Type
4.2.1 Global Brand Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Brand Drugs Forecasted Revenue by Type (2024-2034)
4.2.3 Global Brand Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Brand Drugs Price by Type
4.3.1 Global Brand Drugs Price by Type (2018-2024)
4.3.2 Global Brand Drugs Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Brand Drugs Sales Quantity by Application
5.1.1 Global Brand Drugs Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Brand Drugs Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Brand Drugs Sales Quantity Market Share by Application (2018-2034)
5.2 Global Brand Drugs Revenue by Application
5.2.1 Global Brand Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Brand Drugs Forecasted Revenue by Application (2024-2034)
5.2.3 Global Brand Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Brand Drugs Price by Application
5.3.1 Global Brand Drugs Price by Application (2018-2024)
5.3.2 Global Brand Drugs Price Forecast by Application (2024-2034)
6 North America
6.1 North America Brand Drugs Sales by Company
6.1.1 North America Brand Drugs Revenue by Company (2018-2024)
6.1.2 North America Brand Drugs Sales Quantity by Company (2018-2024)
6.2 North America Brand Drugs Market Size by Type
6.2.1 North America Brand Drugs Sales Quantity by Type (2018-2034)
6.2.2 North America Brand Drugs Revenue by Type (2018-2034)
6.3 North America Brand Drugs Market Size by Application
6.3.1 North America Brand Drugs Sales Quantity by Application (2018-2034)
6.3.2 North America Brand Drugs Revenue by Application (2018-2034)
6.4 North America Brand Drugs Market Size by Country
6.4.1 North America Brand Drugs Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Brand Drugs Revenue by Country (2018-2034)
6.4.3 North America Brand Drugs Sales Quantity by Country (2018-2034)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Brand Drugs Sales by Company
7.1.1 Europe Brand Drugs Sales Quantity by Company (2018-2024)
7.1.2 Europe Brand Drugs Revenue by Company (2018-2024)
7.2 Europe Brand Drugs Market Size by Type
7.2.1 Europe Brand Drugs Sales Quantity by Type (2018-2034)
7.2.2 Europe Brand Drugs Revenue by Type (2018-2034)
7.3 Europe Brand Drugs Market Size by Application
7.3.1 Europe Brand Drugs Sales Quantity by Application (2018-2034)
7.3.2 Europe Brand Drugs Revenue by Application (2018-2034)
7.4 Europe Brand Drugs Market Size by Country
7.4.1 Europe Brand Drugs Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Brand Drugs Revenue by Country (2018-2034)
7.4.3 Europe Brand Drugs Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 UK
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Brand Drugs Sales by Company
8.1.1 China Brand Drugs Sales Quantity by Company (2018-2024)
8.1.2 China Brand Drugs Revenue by Company (2018-2024)
8.2 China Brand Drugs Market Size by Type
8.2.1 China Brand Drugs Sales Quantity by Type (2018-2034)
8.2.2 China Brand Drugs Revenue by Type (2018-2034)
8.3 China Brand Drugs Market Size by Application
8.3.1 China Brand Drugs Sales Quantity by Application (2018-2034)
8.3.2 China Brand Drugs Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Brand Drugs Sales by Company
9.1.1 APAC Brand Drugs Sales Quantity by Company (2018-2024)
9.1.2 APAC Brand Drugs Revenue by Company (2018-2024)
9.2 APAC Brand Drugs Market Size by Type
9.2.1 APAC Brand Drugs Sales Quantity by Type (2018-2034)
9.2.2 APAC Brand Drugs Revenue by Type (2018-2034)
9.3 APAC Brand Drugs Market Size by Application
9.3.1 APAC Brand Drugs Sales Quantity by Application (2018-2034)
9.3.2 APAC Brand Drugs Revenue by Application (2018-2034)
9.4 APAC Brand Drugs Market Size by Region
9.4.1 APAC Brand Drugs Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Brand Drugs Revenue by Region (2018-2034)
9.4.3 APAC Brand Drugs Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Brand Drugs Sales by Company
10.1.1 Middle East, Africa and Latin America Brand Drugs Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Brand Drugs Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Brand Drugs Market Size by Type
10.2.1 Middle East, Africa and Latin America Brand Drugs Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Brand Drugs Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Brand Drugs Market Size by Application
10.3.1 Middle East, Africa and Latin America Brand Drugs Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Brand Drugs Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Brand Drugs Market Size by Country
10.4.1 Middle East, Africa and Latin America Brand Drugs Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Brand Drugs Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Brand Drugs Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Pfizer Brand Drugs Products and Services
11.1.5 Pfizer Brand Drugs SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Overview
11.2.3 Roche Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Roche Brand Drugs Products and Services
11.2.5 Roche Brand Drugs SWOT Analysis
11.2.6 Roche Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Sanofi Brand Drugs Products and Services
11.3.5 Sanofi Brand Drugs SWOT Analysis
11.3.6 Sanofi Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Overview
11.4.3 Johnson & Johnson Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Johnson & Johnson Brand Drugs Products and Services
11.4.5 Johnson & Johnson Brand Drugs SWOT Analysis
11.4.6 Johnson & Johnson Recent Developments
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Information
11.5.2 Merck & Co. (MSD) Overview
11.5.3 Merck & Co. (MSD) Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Merck & Co. (MSD) Brand Drugs Products and Services
11.5.5 Merck & Co. (MSD) Brand Drugs SWOT Analysis
11.5.6 Merck & Co. (MSD) Recent Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Overview
11.6.3 Novartis Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Novartis Brand Drugs Products and Services
11.6.5 Novartis Brand Drugs SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Information
11.7.2 AbbVie Overview
11.7.3 AbbVie Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 AbbVie Brand Drugs Products and Services
11.7.5 AbbVie Brand Drugs SWOT Analysis
11.7.6 AbbVie Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Information
11.8.2 Gilead Sciences Overview
11.8.3 Gilead Sciences Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Gilead Sciences Brand Drugs Products and Services
11.8.5 Gilead Sciences Brand Drugs SWOT Analysis
11.8.6 Gilead Sciences Recent Developments
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Information
11.9.2 GlaxoSmithKline (GSK) Overview
11.9.3 GlaxoSmithKline (GSK) Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 GlaxoSmithKline (GSK) Brand Drugs Products and Services
11.9.5 GlaxoSmithKline (GSK) Brand Drugs SWOT Analysis
11.9.6 GlaxoSmithKline (GSK) Recent Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Overview
11.10.3 Amgen Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Amgen Brand Drugs Products and Services
11.10.5 Amgen Brand Drugs SWOT Analysis
11.10.6 Amgen Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Information
11.11.2 AstraZeneca Overview
11.11.3 AstraZeneca Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 AstraZeneca Brand Drugs Products and Services
11.11.5 AstraZeneca Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Information
11.12.2 Bristol-Myers Squibb Overview
11.12.3 Bristol-Myers Squibb Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Bristol-Myers Squibb Brand Drugs Products and Services
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Overview
11.13.3 Eli Lilly Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Eli Lilly Brand Drugs Products and Services
11.13.5 Eli Lilly Recent Developments
11.14 Teva
11.14.1 Teva Company Information
11.14.2 Teva Overview
11.14.3 Teva Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Teva Brand Drugs Products and Services
11.14.5 Teva Recent Developments
11.15 Bayer
11.15.1 Bayer Company Information
11.15.2 Bayer Overview
11.15.3 Bayer Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Bayer Brand Drugs Products and Services
11.15.5 Bayer Recent Developments
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Information
11.16.2 Novo Nordisk Overview
11.16.3 Novo Nordisk Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Novo Nordisk Brand Drugs Products and Services
11.16.5 Novo Nordisk Recent Developments
11.17 Allergan
11.17.1 Allergan Company Information
11.17.2 Allergan Overview
11.17.3 Allergan Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 Allergan Brand Drugs Products and Services
11.17.5 Allergan Recent Developments
11.18 Takeda
11.18.1 Takeda Company Information
11.18.2 Takeda Overview
11.18.3 Takeda Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.18.4 Takeda Brand Drugs Products and Services
11.18.5 Takeda Recent Developments
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Information
11.19.2 Boehringer Ingelheim Overview
11.19.3 Boehringer Ingelheim Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.19.4 Boehringer Ingelheim Brand Drugs Products and Services
11.19.5 Boehringer Ingelheim Recent Developments
11.20 Takeda
11.20.1 Takeda Company Information
11.20.2 Takeda Overview
11.20.3 Takeda Brand Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.20.4 Takeda Brand Drugs Products and Services
11.20.5 Takeda Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Brand Drugs Value Chain Analysis
12.2 Brand Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Brand Drugs Production Mode & Process
12.4 Brand Drugs Sales and Marketing
12.4.1 Brand Drugs Sales Channels
12.4.2 Brand Drugs Distributors
12.5 Brand Drugs Customers
13 Market Dynamics
13.1 Brand Drugs Industry Trends
13.2 Brand Drugs Market Drivers
13.3 Brand Drugs Market Challenges
13.4 Brand Drugs Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Brand Drugs Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Biopharmaceutical
Table 3. Major Manufacturers of Chemistry Medicine
Table 4. Global Brand Drugs Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Brand Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Brand Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Brand Drugs Revenue Market Share by Region (2018-2024)
Table 8. Global Brand Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Brand Drugs Revenue Market Share by Region (2024-2034)
Table 10. Global Brand Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Brand Drugs Sales by Region (2018-2024) & (K Units)
Table 12. Global Brand Drugs Sales Market Share by Region (2018-2024)
Table 13. Global Brand Drugs Sales by Region (2024-2034) & (K Units)
Table 14. Global Brand Drugs Sales Market Share by Region (2024-2034)
Table 15. Global Brand Drugs Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Brand Drugs Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Brand Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Brand Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Brand Drugs Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Brand Drugs, Industry Ranking, 2021 VS 2022
Table 21. Global Brand Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Brand Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brand Drugs as of 2022)
Table 23. Global Key Manufacturers of Brand Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Brand Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Brand Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Brand Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Brand Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Brand Drugs Sales Quantity Share by Type (2018-2024)
Table 30. Global Brand Drugs Sales Quantity Share by Type (2024-2034)
Table 31. Global Brand Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Brand Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Brand Drugs Revenue Share by Type (2018-2024)
Table 34. Global Brand Drugs Revenue Share by Type (2024-2034)
Table 35. Brand Drugs Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Brand Drugs Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Brand Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Brand Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Brand Drugs Sales Quantity Share by Application (2018-2024)
Table 40. Global Brand Drugs Sales Quantity Share by Application (2024-2034)
Table 41. Global Brand Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Brand Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Brand Drugs Revenue Share by Application (2018-2024)
Table 44. Global Brand Drugs Revenue Share by Application (2024-2034)
Table 45. Brand Drugs Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Brand Drugs Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Brand Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Brand Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Brand Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Brand Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Brand Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Brand Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Brand Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Brand Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Brand Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Brand Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Brand Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Brand Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Brand Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Brand Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Brand Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Brand Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Brand Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Brand Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Brand Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Brand Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Brand Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Brand Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Brand Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Brand Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Brand Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Brand Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Brand Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Brand Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Brand Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Brand Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Brand Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Brand Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Brand Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Brand Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Brand Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Brand Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Brand Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Brand Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Brand Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Brand Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Brand Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Brand Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Brand Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Brand Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Brand Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Brand Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Brand Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Brand Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Brand Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Brand Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Brand Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Brand Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Brand Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Brand Drugs Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Brand Drugs Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Brand Drugs Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Brand Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Brand Drugs Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Brand Drugs Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Brand Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Brand Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Brand Drugs Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Brand Drugs Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Brand Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Brand Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Brand Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Brand Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Brand Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Brand Drugs Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Brand Drugs Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Pfizer Company Information
Table 118. Pfizer Description and Overview
Table 119. Pfizer Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. Pfizer Brand Drugs Product and Services
Table 121. Pfizer Brand Drugs SWOT Analysis
Table 122. Pfizer Recent Developments
Table 123. Roche Company Information
Table 124. Roche Description and Overview
Table 125. Roche Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Roche Brand Drugs Product and Services
Table 127. Roche Brand Drugs SWOT Analysis
Table 128. Roche Recent Developments
Table 129. Sanofi Company Information
Table 130. Sanofi Description and Overview
Table 131. Sanofi Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. Sanofi Brand Drugs Product and Services
Table 133. Sanofi Brand Drugs SWOT Analysis
Table 134. Sanofi Recent Developments
Table 135. Johnson & Johnson Company Information
Table 136. Johnson & Johnson Description and Overview
Table 137. Johnson & Johnson Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. Johnson & Johnson Brand Drugs Product and Services
Table 139. Johnson & Johnson Brand Drugs SWOT Analysis
Table 140. Johnson & Johnson Recent Developments
Table 141. Merck & Co. (MSD) Company Information
Table 142. Merck & Co. (MSD) Description and Overview
Table 143. Merck & Co. (MSD) Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. Merck & Co. (MSD) Brand Drugs Product and Services
Table 145. Merck & Co. (MSD) Brand Drugs SWOT Analysis
Table 146. Merck & Co. (MSD) Recent Developments
Table 147. Novartis Company Information
Table 148. Novartis Description and Overview
Table 149. Novartis Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 150. Novartis Brand Drugs Product and Services
Table 151. Novartis Brand Drugs SWOT Analysis
Table 152. Novartis Recent Developments
Table 153. AbbVie Company Information
Table 154. AbbVie Description and Overview
Table 155. AbbVie Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 156. AbbVie Brand Drugs Product and Services
Table 157. AbbVie Brand Drugs SWOT Analysis
Table 158. AbbVie Recent Developments
Table 159. Gilead Sciences Company Information
Table 160. Gilead Sciences Description and Overview
Table 161. Gilead Sciences Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 162. Gilead Sciences Brand Drugs Product and Services
Table 163. Gilead Sciences Brand Drugs SWOT Analysis
Table 164. Gilead Sciences Recent Developments
Table 165. GlaxoSmithKline (GSK) Company Information
Table 166. GlaxoSmithKline (GSK) Description and Overview
Table 167. GlaxoSmithKline (GSK) Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 168. GlaxoSmithKline (GSK) Brand Drugs Product and Services
Table 169. GlaxoSmithKline (GSK) Brand Drugs SWOT Analysis
Table 170. GlaxoSmithKline (GSK) Recent Developments
Table 171. Amgen Company Information
Table 172. Amgen Description and Overview
Table 173. Amgen Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 174. Amgen Brand Drugs Product and Services
Table 175. Amgen Brand Drugs SWOT Analysis
Table 176. Amgen Recent Developments
Table 177. AstraZeneca Company Information
Table 178. AstraZeneca Description and Overview
Table 179. AstraZeneca Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 180. AstraZeneca Brand Drugs Product and Services
Table 181. AstraZeneca Recent Developments
Table 182. Bristol-Myers Squibb Company Information
Table 183. Bristol-Myers Squibb Description and Overview
Table 184. Bristol-Myers Squibb Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 185. Bristol-Myers Squibb Brand Drugs Product and Services
Table 186. Bristol-Myers Squibb Recent Developments
Table 187. Eli Lilly Company Information
Table 188. Eli Lilly Description and Overview
Table 189. Eli Lilly Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 190. Eli Lilly Brand Drugs Product and Services
Table 191. Eli Lilly Recent Developments
Table 192. Teva Company Information
Table 193. Teva Description and Overview
Table 194. Teva Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 195. Teva Brand Drugs Product and Services
Table 196. Teva Recent Developments
Table 197. Bayer Company Information
Table 198. Bayer Description and Overview
Table 199. Bayer Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 200. Bayer Brand Drugs Product and Services
Table 201. Bayer Recent Developments
Table 202. Novo Nordisk Company Information
Table 203. Novo Nordisk Description and Overview
Table 204. Novo Nordisk Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 205. Novo Nordisk Brand Drugs Product and Services
Table 206. Novo Nordisk Recent Developments
Table 207. Allergan Company Information
Table 208. Allergan Description and Overview
Table 209. Allergan Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 210. Allergan Brand Drugs Product and Services
Table 211. Allergan Recent Developments
Table 212. Takeda Company Information
Table 213. Takeda Description and Overview
Table 214. Takeda Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 215. Takeda Brand Drugs Product and Services
Table 216. Takeda Recent Developments
Table 217. Boehringer Ingelheim Company Information
Table 218. Boehringer Ingelheim Description and Overview
Table 219. Boehringer Ingelheim Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 220. Boehringer Ingelheim Brand Drugs Product and Services
Table 221. Boehringer Ingelheim Recent Developments
Table 222. Takeda Company Information
Table 223. Takeda Description and Overview
Table 224. Takeda Brand Drugs Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 225. Takeda Brand Drugs Product and Services
Table 226. Takeda Recent Developments
Table 227. Key Raw Materials Lists
Table 228. Raw Materials Key Suppliers Lists
Table 229. Brand Drugs Distributors List
Table 230. Brand Drugs Customers List
Table 231. Brand Drugs Market Trends
Table 232. Brand Drugs Market Drivers
Table 233. Brand Drugs Market Challenges
Table 234. Brand Drugs Market Restraints
Table 235. Research Programs/Design for This Report
Table 236. Key Data Information from Secondary Sources
Table 237. Key Data Information from Primary Sources
List of Figures
Figure 1. Brand Drugs Product Picture
Figure 2. Global Brand Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Brand Drugs Market Share by Type in 2022 & 2034
Figure 4. Biopharmaceutical Product Picture
Figure 5. Chemistry Medicine Product Picture
Figure 6. Global Brand Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Brand Drugs Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Brand Drugs Report Years Considered
Figure 12. Global Brand Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Brand Drugs Revenue 2018-2034 (US$ Million)
Figure 14. Global Brand Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Brand Drugs Sales Quantity 2018-2034 (K Units)
Figure 16. Global Brand Drugs Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Brand Drugs Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Brand Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Brand Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Brand Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Brand Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Brand Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Brand Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Brand Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Brand Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Brand Drugs Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Brand Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Brand Drugs Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Brand Drugs Revenue in 2022
Figure 30. Brand Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Brand Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Brand Drugs Revenue Market Share by Type (2018-2034)
Figure 33. Global Brand Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Brand Drugs Revenue Market Share by Application (2018-2034)
Figure 35. North America Brand Drugs Revenue Market Share by Company in 2022
Figure 36. North America Brand Drugs Sales Quantity Market Share by Company in 2022
Figure 37. North America Brand Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Brand Drugs Revenue Market Share by Type (2018-2034)
Figure 39. North America Brand Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Brand Drugs Revenue Market Share by Application (2018-2034)
Figure 41. North America Brand Drugs Revenue Share by Country (2018-2034)
Figure 42. North America Brand Drugs Sales Quantity Share by Country (2018-2034)
Figure 43. the United States Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Brand Drugs Sales Quantity Market Share by Company in 2022
Figure 46. Europe Brand Drugs Revenue Market Share by Company in 2022
Figure 47. Europe Brand Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Brand Drugs Revenue Market Share by Type (2018-2034)
Figure 49. Europe Brand Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Brand Drugs Revenue Market Share by Application (2018-2034)
Figure 51. Europe Brand Drugs Revenue Share by Country (2018-2034)
Figure 52. Europe Brand Drugs Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 54. France Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 55. UK Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 58. China Brand Drugs Sales Quantity Market Share by Company in 2022
Figure 59. China Brand Drugs Revenue Market Share by Company in 2022
Figure 60. China Brand Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Brand Drugs Revenue Market Share by Type (2018-2034)
Figure 62. China Brand Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Brand Drugs Revenue Market Share by Application (2018-2034)
Figure 64. APAC Brand Drugs Sales Quantity Market Share by Company in 2022
Figure 65. APAC Brand Drugs Revenue Market Share by Company in 2022
Figure 66. APAC Brand Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Brand Drugs Revenue Market Share by Type (2018-2034)
Figure 68. APAC Brand Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Brand Drugs Revenue Market Share by Application (2018-2034)
Figure 70. APAC Brand Drugs Revenue Share by Region (2018-2034)
Figure 71. APAC Brand Drugs Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 76. India Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Brand Drugs Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Brand Drugs Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Brand Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Brand Drugs Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Brand Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Brand Drugs Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Brand Drugs Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Brand Drugs Revenue Share by Country (2018-2034)
Figure 85. Brazil Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Brand Drugs Revenue (2018-2034) & (US$ Million)
Figure 90. Brand Drugs Value Chain
Figure 91. Brand Drugs Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed